Coronavirus disease (COVID-19) is caused by SARS-COV2, which denotes the causative agent of a potentially lethal disease that is of great global public health concern. Although most of the COVID-19 patients get better and return to their normal health, only a few patients have symptoms that can last for weeks or even months’ later recovery from acute illness. Post COVID complications are deteriorating the health-related quality of life of the survivors, thereby making their condition worse. The main aim of this study is to assess the impact and the complications of the COVID-19. The objectives of the study are to know the extent of the long-term complications affects the quality of life of the COVID-19 cured subjects and to assess the impact of post-covid complications on the physical health of the COVID survivors. It is a hospital-based retro-prospective study involving 210 subjects. The data was collected by using the patient interviews, laboratory reports and by the questionnaire developed. Data was analyzed by using the GraphPad Prism 9.1.2(226) software. In our study of 210 patients about 77% were using the nutritional supplements after the COVID-19 recovery. Most of them were using nutritional supplements to overcome the fatigue caused by the COVID attack. It was observed that 52% of subjects were depressed during the covid attack.

REFERENCES

1. Wu YC, Chen CS, Chan YJ. The outbreak of COVID-19: An overview. J Chin Med Assoc. 2020 Mar;83(3):217-220.
2. Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed. 2020 Mar 19;91(1):157-160.
3. Perlman S. Another Decade, Another Coronavirus. New England Journal Medicine. 2020 Feb 20;382(8):760-762.
4. Jin Y, Yang H, Ji W, Wu W, Chen S, Zhang W, Duan G. Virology, Epidemiology, Pathogenesis, and Control of COVID-19. Viruses. 2020; 12(4):372.
5. Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for Gastrointestinal Infection of SARS-CoV-2. Gastroenterology. 2020 May;158(6):1831-1833.
6. Xin Zou1, Ke Chen1, Jiawei Zou1, Peiyi Han2, Jie Hao, Zeguang Han. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection.2020. Front. Med. 2020, 14(2): 185–192
7. Centres for Disease control and prevention COVID-19 management (https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html)
8. Coronavirus disease (COVID-19).12 October 2020; Q&A (https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-covid-19)
9. Mayo clinic Coronavirus disease (COVID-19) diagnosis, treatment. ((https://www.mayoclinic.org/diseases-conditions/coronavirus/symptoms-causes/syc-20479963)
10. Centres for Disease control and prevention, Post-COVID Conditions Updated Apr. 8, 2021(https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects.html)
11. Javed B, Sarwer A, Soto EB, Mashwani ZU. The coronavirus (COVID-19) pandemic's impact on mental health. Int J Health Plann Manage. 2020 Sep;35(5):993-996.
12. Samantha K Brooks, Rebecca K Webster, Louise E Smith, Lisa Woodland, Simon Wessely, Neil Greenberg, Gideon James Rubin, the psychological impact of quarantine and how to reduce it: rapid review of the evidence,2020, The Lancet, Volume 395, Issue 10227, Pages 912-920.
13. Khan, K.S., Mamun, M.A., Griffiths, M.D. et al. The Mental Health Impact of the COVID-19 Pandemic Across Different Cohorts. Int J Ment Health Addiction (2020).
14. NEWS FEATURE The race for coronavirus vaccines: a graphical guide .28 April 2020. Nature 580, 576-577. ( https://www.nature.com/articles/d41586-020-01221-y)
15. Khan, Sharun & Rahman, C.K Faslu & C V, Haritha & Jose, Bosco & Tiwari, Ruchi & Dhama, Kuldee. COVID-19 Vaccine Acceptance: Beliefs and Barriers Associated with Vaccination Among the General Population in India.2020. Journal of Experimental Biology and Agricultural Sciences. 8. S210-S218.
16. Bijaya Kumar Padhi, Mohammed Al-Mohaithef. Determinants of COVID-19 vaccine acceptance in Saudi Arabia: a web-based national survey.2020. medRxiv 2020.05.
17. Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax. 2020 Dec 3;76(4):405–7.
18. Nwachukwu I, Nkire N, Shalaby R, Hrabok M, Vuong W, Gusnowski A, Surood S, Urichuk L, Greenshaw AJ, Agyapong VI. COVID-19 Pandemic: Age-Related Differences in Measures of Stress, Anxiety and Depression in Canada. International Journal of Environmental Research and Public Health. 2020 Jan;17(17):6366.
19. Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. 2021 Mar;75(3):e13746.
20. Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. 2021 Mar;75(3):e13746.
21. Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, Ho RC. Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China. International Journal of Environmental Research and Public Health. 2020; 17(5):1729
22. Mandal S, Barnett J, Brill SE ARC Study Group, et al., ‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19., Thorax 2021;76:396-398.
23. Hall J, Myall K, Lam JL, et al., Identifying patients at risk of post-discharge complications related to COVID-19 infection., Thorax 2021;76:408-411.
24. Carfì A, Bernabei R, Landi F, for the Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603–605.

Khan, Sharun & Rahman, C.K Faslu & C V, Haritha & Jose, Bosco & Tiwari, Ruchi & Dhama, Kuldeep. (2020). COVID-19 Vaccine Acceptance: Beliefs and Barriers Associated with Vaccination Among the General Population in India. Journal of Experimental Biology and Agricultural Sciences. 8. S210-S218. 10.18006/2020